Down-regulation of delta opioid receptor mRNA by an anabolic steroid in neuronal hybrid cells

NeuroReport

Volumn 11, Issue 4, 2000, Pages 863-867

  Pasquariello, Anna ^a   Di Toro, Rosanna ^b   Nyberg, Fred ^a   Spampinato, Santi ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Anabolic androgenic steroids; Delta opioid receptor; Dexamethasone; Gene expression; MRNA; Nandrolone; Neuronal hybrid cell

Indexed keywords

DELTA OPIATE RECEPTOR; DEXAMETHASONE; FLUTAMIDE; MESSENGER RNA; NANDROLONE; STEROID;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; DRUG RECEPTOR BINDING; GENE CONTROL; GENE INDUCTION; GENE REPRESSION; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; RNA TRANSCRIPTION;

EID: 0034689191     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200003200-00041     Document Type: Article

References (28)

1. 1. Lukas SE. Annu Rev Pharmacol Toxicol 36, 333-357 (1996).
2. 2. Tsai M-J and O'Malley BW. Annu Rev Biochem 63, 451-486 (1995).
3. 3. Flanagan-Cato LM and Fluharty SJ. Curr Opin Neurobiol 7, 844-849 (1997).
4. 4. Woolley CS. Curr Opin Neurobiol 9, 349-354 (1999).
5. 5. Rosner W, Hryb DJ, Khan MS et al. Steroids 64, 100-106 (1999).
6. 6. Thiblin I, Finn A, Ross SB and Stenfors C. Br J Pharmacol 126, 1301-1306 (1999).
7. 7. Le Grevès P, Huang W, Johansson P et al. Neurosci Lett 226, 61-64 (1997).
8. 8. Masonis AE and McCarthy MP. J Steroid Biochem Mol Biol 58, 551-555 (1996).
9. 9 Johansson P, Ray A, Zhou Q et al. Neurosci Res 27, 185-189 (1997).
10. 10. Kieffer BL. Trends Pharmacol Sci 20, 19-26 (1999).
11. 11. Piva F, Limonta P, Dondi D et al. J Steroid Biochem Mol Biol 53, 343-348 (1995).
12. 12. Menard CS, Hebert TJ, Dohanich GP and Harlan RE. Brain Res 669, 255-262 (1995).
13. 13. Spampinato S, Canossa M, Bachetti T et al. Brain Res 580, 225-232 (1992).
14. 14. Zhou L and Hammer RP Jr. Eur J Pharmacol 278, 271-274 (1995).
15. 15. Thom B, Canny BJ, Cowley M et al. J Endocrinol 149, 509-518 (1996).
16. 16. Di Toro R, Campana G, Sciarretta V et al. Life Sci 63, PL197-PL204 (1998).
17. 17. Maggi R, Pimpinelli F, Martini L and Piva F. Endocrinology 136, 289-295 (1995).
18. 18. Poletti A, Melcangi RC, Negri-Cesi P et al. Endocrinology 135, 2623-2628 (1994).
19. 19. Munson PJ and Rodbard D. Anal Biochem 107, 220-239 (1980).
20. 20. Xing RH and Rabbani SA. Endocrinology 140, 4056-4064 (1999).
21. 21. Wolf DA, Herzinger T, Hermeking H et al. Mol Endocrinol 7, 924-936 (1993).
22. 22. Mayer M and Rosen F. Am J Physiol 229, 1381-1386 (1975).
23. 23. Fernandez L, Boada LD, Luzardo OP et al. Pharmacol Toxicol 77, 264-269 (1995).
24. 24. Yoshikawa K and Sabol SL. Biochem Biophys Res Commun 139, 1-10 (1986).
25. 25. Chandran UR, Attardi B, Friedman R et al. Endocrinology 134, 1467-1474 (1994).
26. 26. Quinones-Jenab V, Jenab S, Ogawa S et al. Brain Res Mol Brain Res 47, 134-138 (1997).
27. 27. Yukhananov RY and Handa PJ. Neuroreport 7, 1690-1694 (1996).
28. 28. LaBella FS, Song Kim R-S and Templeton J. Life Sci 23, 1797-1804 (1978).